123 related articles for article (PubMed ID: 8195835)
21. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
Fritsche TR; Stilwell MG; Jones RN
Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
[TBL] [Abstract][Full Text] [Related]
23. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
24. Comparative antibacterial spectrum of trimethoprim and brodimoprim.
Amyes SG
J Chemother; 1993 Dec; 5(6):417-21. PubMed ID: 8195832
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli.
Chiaradia V; Pascoli L; Santini G
Chemioterapia; 1985 Aug; 4(4):284-8. PubMed ID: 3931923
[TBL] [Abstract][Full Text] [Related]
26. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve].
Soussy CJ; Cluzel M; Derlot E; Kitzis MD; Meyran M
Pathol Biol (Paris); 1994 May; 42(5):385-92. PubMed ID: 7824301
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
Gismondo MR; Chisari G; Lo Bue AM
Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine.
Carlone NA; Cuffini AM; Forno Pizzoglio M; Cavallo G
Drugs Exp Clin Res; 1985; 11(7):447-51. PubMed ID: 3836867
[TBL] [Abstract][Full Text] [Related]
29. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
Bismuth R; Jarlier V; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
[TBL] [Abstract][Full Text] [Related]
30. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
[TBL] [Abstract][Full Text] [Related]
31. Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
Davila D; Tambić T; Djokić S; Kolacny-Babić L
Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164
[TBL] [Abstract][Full Text] [Related]
32. Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines.
Uria-Nickelsen M; Neckermann G; Sriram S; Andrews B; Manchester JI; Carcanague D; Stokes S; Hull KG
Int J Antimicrob Agents; 2013 Apr; 41(4):363-71. PubMed ID: 23305654
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra.
Bayer AS; Lam K
Clin Ther; 1983; 5(4):391-7. PubMed ID: 6871922
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
Focà A; Liberto MC; Berlinghieri MC; Matera G; Puccio R; Carbone M; Fera MT
Drugs Exp Clin Res; 1990; 16(4):175-9. PubMed ID: 2076653
[TBL] [Abstract][Full Text] [Related]
35. [Comparative urinary bactericidal activity of oral antibiotics against gram-positive pathogens].
Bedenić B; Budimir A; Gverić A; Plecko V; Vranes J; Bubonja-Sonje M; Kalenić S
Lijec Vjesn; 2012; 134(5-6):148-55. PubMed ID: 22930932
[TBL] [Abstract][Full Text] [Related]
36. Multi-centre collaborative study for the in vitro evaluation of new macrolides dirithromycin and erythromycylamine. Australian Group for Antimicrobial Resistance (AGAR).
Fernandes CJ; Benn RA; Nimmo GR
Pathology; 1995 Jan; 27(1):74-8. PubMed ID: 7603759
[TBL] [Abstract][Full Text] [Related]
37. [Susceptibility to roxithromycin of gram-positive cocci isolated from patients with lowered immunity].
Mróz E; Podolak-Dawidziak M; Grzybek-Hryncewicz K; Dworniczek E
Med Dosw Mikrobiol; 1994; 46(1-2):5-8. PubMed ID: 7967928
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity of rokitamycin compared with that of other macrolides.
Yu KW; Briones F; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
[TBL] [Abstract][Full Text] [Related]
39. New antimicrobial peptide active against Gram-positive pathogens.
Jasir A; Kasprzykowski F; Lindström V; Schalén C; Grubb A
Indian J Med Res; 2004 May; 119 Suppl():74-6. PubMed ID: 15232166
[TBL] [Abstract][Full Text] [Related]
40. [Determination of the sensitivity of bacteria to antibiotics by an agar diffusion method and use of the API ATB system: a comparative study].
Reynaud AE; Coude du Foresto B; Courtieu AL
Ann Biol Clin (Paris); 1989; 47(2):71-5. PubMed ID: 2735566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
